UPDATE 1-Pfizer set to buy Allergan for more than $150 bln-sources

Nov 22 (Reuters) - Pfizer Inc was due to secure formal board approval on Sunday for its acquisition of Botox maker Allergan Plc for more than $150 billion, making it the healthcare sector's largest deal ever, according to people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.